Thavandiran, Nimalan
Hale, Christopher http://orcid.org/0000-0002-2360-7759
Blit, Patrick
Sandberg, Mark L.
McElvain, Michele E.
Gagliardi, Mark
Sun, Bo
Witty, Alec
Graham, George
Do, Van T.H.
Bakooshli, Mohsen Afshar
Le, Hon
Ostblom, Joel http://orcid.org/0000-0003-0051-3239
McEwen, Samuel
Chau, Erik
Prowse, Andrew
Fernandes, Ian
Norman, Andreea
Gilbert, Penney M.
Keller, Gordon
Tagari, Philip
Xu, Han
Radisic, Milica http://orcid.org/0000-0003-1249-4135
Zandstra, Peter W.
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research
Article History
Received: 1 August 2019
Accepted: 18 March 2020
First Online: 24 April 2020
Competing interests
: N.T., M.R., and P.W.Z. are co-inventors on a patent covering the design of cardiac microtissue formation: “Cardiac tissue constructs and methods of fabrication thereof”. N.T. and M.R. are co-inventors on a patent covering the design of microtissue formation: “Compositions and methods for making and using three-dimensional tissue systems”. C.H., P.T., and H.L. are employees of Amgen Inc. Amgen has an interest in cardiac-associated drug discovery and contributed to this study. H.X., M.L.S., and M.E.M. are current employees of A2 Biotherapeutics Inc., and previous employees of Amgen Inc. A2 Biotherapeutics has an interest in cardiac-associated drug discovery. M.R. holds equity in and receives consulting income from TARA Biosystems, a company that uses heart tissues in drug discovery.